ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CAH vs COR // OPTIONS IMPLIED MOVE & PUT/CALL SKEW

Cardinal Health Inc. (NYSE) VS. Cencora Inc. (NYSE) • 15-METRIC TALLY: CAH 8 — COR 5
■ METRIC PARITY
options-implied-move
—
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CAH VS. COR) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CAH COR SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 3.70% 3.60% +0.10 CAH /gross-margins <GO>
Return on Invested Capital (ROIC) 29.70% 26.80% +2.90 CAH /roic <GO>
EV/EBITDA & P/E Valuation 24.5x 21.6x +2.90 COR /valuation <GO>
Free Cash Flow Yield 3.18% 5.08% -1.90 COR /fcf-yield <GO>
Operating Margin 1.00% 0.80% +0.20 CAH /operating-margins <GO>
Net Profit Margin 0.70% 0.50% +0.20 CAH /net-margins <GO>
Revenue Growth (YoY) -1.90% 9.30% -11.20 COR /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.85% 0.69% +0.16 CAH /dividend-safety <GO>
Altman Z-Score & Debt/Equity 5.16 5.27 -0.11 COR /balance-sheet <GO>
Piotroski F-Score Quality 6/9 6/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew ACTIVE — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 59.1 53.8 +5.30 CAH /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 0.90 0.88 +0.02 CAH /macro-sensitivity <GO>
Forward P/E Multiple 34.6x 37.8x -3.20 CAH /forward-pe <GO>
Enterprise Scale & Market Cap $58.14B $63.07B -$4.93B COR /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CAH REV COR REV CAH GROSS % COR GROSS % CAH FCF COR FCF
FY 2025 $222.58B $321.33B 3.7% 3.6% $1.85B $3.21B
FY 2024 $226.83B $293.96B 3.3% 3.4% $3.25B $3.00B
FY 2023 $204.98B $262.17B — — -$6.38B -$7.89B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CAH // BETA 0.90
COR // BETA 0.88